X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.fiercepharma.com/pharma/merck-raises-revenue-guidance-thanks-surprising-bump-covid-19-pill-lagevrio
https://www.fiercepharma.com/pharma/mercks-lagevrio-hit-commercial-market-november-hhs-says
https://www.fiercepharma.com/pharma/has-mercks-lagevrio-fueled-evolution-covid-variants-researchers-say-its-possible
https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-merck-trim-prices-china-paxlovid-molnupiravir-reports-2023-04-04/
https://endpts.com/merck-asks-ema-to-reevaluate-rejected-covid-19-antiviral/
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-recommends-against-approval-mercks-covid-pill-adults-2023-02-24/
https://endpts.com/merck-falls-short-in-phiii-covid-19-prophylaxis-trial-joining-pfizer/
https://www.caixinglobal.com/2022-12-31/china-approves-mercks-covid-pill-amid-shortage-of-drugs-101984066.html
https://www.pharmafile.com/news/744119/covid-19-antiviral-treatment-shown-speed-recovery-trial
https://www.clinicaltrialsarena.com/news/ascletis-covid-prodrug-trial/
https://www.prnewswire.com/news-releases/ascletis-announces-positive-phase-i-clinical-results-of-oral-rdrp-inhibitor-asc10-for-covid-19-301700402.html
https://www.fiercepharma.com/pharma/merck-agrees-deal-sinopharm-commercialize-covid-19-pills-china
https://endpts.com/fda-says-it-wont-allow-state-licensed-pharmacists-to-prescribe-mercks-lagevrio/
https://www.fiercepharma.com/pharma/icer-says-pfizers-paxlovid-mercks-molnupiravir-both-cost-effective-drugs-benefit-far-equal
https://www.reuters.com/business/merck-quarterly-profit-tops-expectations-demand-covid-pill-cancer-drugs-2022-04-28/
https://www.bnnbloomberg.ca/pfizer-s-covid-pill-get-who-endorsement-for-high-risk-patients-1.1755261
https://www.fiercepharma.com/pharma/pfizers-covid-pill-paxlovid-gets-big-boost-britain-thanks-spot-national-trial
https://www.fiercepharma.com/pharma/pfizers-covid-pill-paxlovid-gets-big-boost-britain-thanks-spot-national-trial
https://endpts.com/who-oks-molnupiravir-as-treatment-for-covid-19-despite-continuing-questions/
https://www.tribuneindia.com/news/brand-connect/lessons-learnt-from-the-second-wave-tracking-possibility-of-drug-demand-and-supply-gap-with-omicron-wreaking-havoc-372134
https://www.theguardian.com/commentisfree/2022/feb/20/covid-treatment-pill-big-pharma-antiviral-drugs
https://endpts.com/fda-updates-mercks-covid-19-pill-eua-and-reaffirms-it-should-only-be-used-as-a-last-resort/
https://www.forbes.com/sites/zacharysmith/2022/02/19/mercks-anti-covid-pill-shows-better-effectiveness-in-indian-study/?sh=5d955e166fc7
https://www.pharmaceutical-technology.com/news/kalbe-amarox-market-covid-19-drug/
https://www.news-medical.net/news/20220214/Researchers-identify-a-powerful-combination-of-antivirals-to-treat-COVID-19.aspx
https://www.reuters.com/business/merck-sees-2022-sales-up-nearly-20-mostly-molnupiravir-2022-02-03/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/laurus-labs-inks-pact-with-mpp-to-produce-molnupiravir/articleshow/89033582.cms
https://www.thehindubusinessline.com/news/natco-biophore-pharma-get-nod-to-manufacture-market-molnupiravir/article64927523.ece
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-signs-pact-with-mpp-to-sell-molnupiravir-capsules/articleshow/89018487.cms
https://www.pharmatimes.com/news/beximco_pharma_to_manufacture_molnupiravir_for_covid-19_1386570
https://www.pharmaceutical-technology.com/news/australian-tga-two-oral-medicines-covid-19/
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/molnupiravir-not-included-in-covid-19-treatment-guidelines-as-its-harms-outweigh-benefits-icmr/articleshow/88859184.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/molnupiravir-shouldnt-be-given-to-people-of-reproductive-age-dr-nk-arora-warns-on-anti-covid-pill/videoshow/88838920.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/molnupiravir-not-to-be-included-in-covid-19-clinical-management-protocol-as-of-now/articleshow/88833421.cms
Market Place
Share 
